The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) |
93.846, 93.855 |
PA-25-093 |
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) |
93.853 |
PAR-25-050 |
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required) |
93.399 |
RFA-CA-25-009 |
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required) |
93.399 |
RFA-CA-25-010 |
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
93.172, 93.213, 93.310, 93.350, 93.846, 93.853, 93.855, 93.859, 93.867, 93.879 |
PA-25-080 |
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) |
93.173 |
PAR-25-020 |
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) |
93.853 |
PAR-25-055 |
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.866, 93.867 |
PAR-24-293 |
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) |
93.393 |
RFA-CA-25-013 |
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed) |
93.279 |
RFA-DA-26-009 |
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed) |
93.279 |
RFA-DA-26-010 |
Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed) |
93.393, 93.396 |
RFA-CA-24-036 |
National Evaluation Center (NEC) for AHRQs Healthcare Extension Service: State-based Solutions to Healthcare Improvement (U19) |
93.226 |
RFA-HS-24-005 |
Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-25-022 |
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) |
93.853 |
RFA-NS-25-024 |
National Coordinating Center (NCC) for AHRQs Healthcare Extension Service - State-based Solutions to Healthcare Improvement (U54) |
93.226 |
RFA-HS-24-006 |
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-26-120 |
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.853, 93.866, 93.867 |
PAR-25-051 |
Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional) |
93.313, 93.361 |
RFA-NR-25-001 |
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
93.273, 93.279 |
PAR-24-299 |
NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) |
93.865 |
PAR-24-301 |
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-25-017 |
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) |
93.213, 93.242, 93.273, 93.279, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-25-018 |
Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-24-065 |
Fair Housing Initiatives Program - Private Enforcement Initiative |
14.418 |
FR-6800-N-21-C |
Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional) |
93.242 |
RFA-MH-25-200 |
Fair Housing Initiatives Program -Education and Outreach Initiative -Test Coordinator Training |
14.416 |
FR-6800-N-71-A |
Older Adults Home Modification Grant Program |
14.921 |
FR-6800-N-69 |
Fair Housing Initiatives Program Education and Outreach Initiative |
14.416 |
FR-6800-N-21-A |
Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional) |
93.279 |
PAR-24-298 |
Fair Housing Initiative Program - Fair Housing Organizations Initiative |
14.417 |
FR-6800-N-21-B |
Consolidated Multifamily Housing Technical Assistance Grant Programs |
10.494, 10.495 |
USDA-RD-HCFP-NPTA-FLHTA-2024 |
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) |
93.121, 93.213, 93.273, 93.393, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-25-023 |
Cellular Models of HIV Pathogenesis within NIDDK Mission Areas (R01 Clinical Trial Not Allowed) |
93.313, 93.847 |
RFA-DK-25-021 |
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) |
93.279 |
PAR-24-297 |
Solid Waste Infrastructure for Recycling (SWIFR) Grants for Tribes and Intertribal Consortia |
66.920 |
EPA-I-OLEM-ORCR-24-06 |
Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-26-002 |
Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research in Low- and Middle-Income Countries (LMICs) (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-25-014 |
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) |
93.213 |
PAR-24-275 |
DE-FOA-0003371 FY24 Scale-Up of Integrated Biorefineries |
81.087 |
DE-FOA-0003371 |
Search Results 521-560 of 18491 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 [Next] |